JAMES BELUE: Open Payments
NPI 1871520023 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 12 payments from 8 companies in 2025. Trend: 2023 $199 · 2024 $230 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $74 |
| ABBVIE INC. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| Abbott Laboratories | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: FARXIGA, VRAYLAR, SPRAVATO, FREESTYLE LIBRE 3, JOURNAVX, BREZTRI, Cologuard Collection Kit, Veozah.
Industry payments across LA — which companies pay providers there.
